This study was completed To guage the likely in the CPPs with tumor-concentrating on Houses to deliver a cytotoxic payload to HCC cells. We explored utilizing a CXCR4-targeting peptide, T22, fused with cytotoxic peptide PE24, for a novel therapeutic tactic for CXCR4+ HCC cells. T22 was preferred as being the nanocarrier as a result of its well-prov